Synchron, backed by Jeff Bezos and Bill Gates, is emerging as a strong competitor to Elon Musk's Neuralink in the brain-computer interface (BCI) industry.

Synchron focuses on minimally invasive technology, using a stent-like device inserted via blood vessels to connect the brain to computers.

With promising early trials, it is preparing for large-scale human trials, aiming to provide solutions for neurological conditions such as paralysis.

While Neuralink seeks more direct brain implantation methods, Synchron’s approach could offer a safer, less invasive alternative as the BCI field expands.